MRA Announces RFP for Translational Research
16 September 2015 In Science
MRA is pleased to announce a Request for Proposals (RFP) soliciting high-impact translational research from scientists and clinicians around the world. This RFP is for 2015-2016, with awards being announced in the spring of 2016. The RFP calls for ideas that have the potential to lead to near-term clinical application...
Researcher Q&A: Dr. Neil Ganem
2 September 2015 In Science
In an effort to share more about the work being done in the field of melanoma research, we are beginning a new feature on our blog to showcase some of our funded investigators. Today we’re talking with Neil Ganem, Ph.D., Assistant Professor of Pharmacology and Medicine at Boston University School of...
Immunotherapy for Melanoma: Where We Are
28 August 2015 In Science
As was reported last week, Former President Jimmy Carter has melanoma that has spread to other organs, and part of his treatment will include an immunotherapy drug. Immunotherapy is a term used to describe treatments that harness the body’s immune system to fight cancer cells.
What We Can Learn from President Carter’s Melanoma Diagnosis and Treatment
By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 21 August 2015 In Treatment
President Jimmy Carter revealed to the world his diagnosis with melanoma with both the grace and bravery that we may all aspire to in the face of such news. His melanoma presentation was a bit unusual and naturally confusing.
Join Us in Helping Americans Stay Sun Safe This Summer
6 August 2015 In Allies & Partnerships
Today’s blog post is from our partners at Lands End. See how they are joining the fight against melanoma – and how you can get involved. Skin cancer is the most common form of cancer in the United States and Lands’ End wants to keep your skin safe! We are...
Taking a Closer Look at MRA’s Recent Grant Funding
By Laura Brockway-Lunardi, PhD, MRA Scientific Program Director | 23 July 2015 In Science, Treatment
Melanoma Research Alliance has awarded almost $68 million to 237 PIs at 99 institutions in 14 countries since its founding in 2007
Sports Authority Helps to Shine Some Light on Melanoma
In recognition of Melanoma Awareness Month in May, Sports Authority deployed its fifth in-store donation and consumer awareness campaign to raise money for MRA’s research program and to educate customers on ways to reduce their risk of melanoma.
Ups and Downs for Melanoma. But Staying Focused.
By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 25 June 2015 In Science
This time a week ago I was jubilant. The SU2C-MRA Melanoma Dream Team’s paper describing a precision medicine approach to treating patients had just been published. And in the middle of the week an important article published in the prestigious scientific journal Cell describing the comprehensive genomic landscape of over...
On the Path to Precision Medicine for Melanoma Patients
By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 16 June 2015 In Science
There is no denying the transformative success of new treatments for melanoma ranging from molecularly targeted agents for BRAF-mutant melanoma to immunotherapies like anti-CTLA4 and anti-PD-1 drugs. Indeed, the treatment of BRAF-mutant melanoma is a prime example of Precision Medicine; that is, matching treatments to a patient’s specific disease.
Adjuvant Therapy Advocacy ASCO Awareness Board Members BRAF Cancer Combination Therapy Detection FDA Grants Immunotherapy Melanoma microbiome MRA Partners Patient Forum Patient Stories Patient-Centric Care Patients Pediatric Melanoma Prevention Research Science Social Media Targeted Therapy Teens Treatment Wendy Selig Young Investigators Young People